about
Nutrition, a health technology that deserves increasing interest among HTA doers. A systematic reviewColorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain).Information needs of health technology assessment units and agencies in Spain.Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugsThe GRADE approach for assessing new technologies as applied to apheresis devices in ulcerative colitis.Nutrition economics - characterising the economic and health impact of nutrition.Post-marketing health technology monitoring. The analysis of an experience from a clinical perspective.Workshop Report: concepts and methods in the economics of nutrition--gateways to better economic evaluation of nutrition interventions.Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.Policies of screening for colorectal cancer in European countries.The Life Cycle of Health Technologies. Challenges and Ways Forward.Guiding the process of health technology disinvestment.Post-introduction observation of healthcare technologies after coverage: the Spanish proposal.HEALTH TECHNOLOGY PERFORMANCE ASSESSMENT: REAL-WORLD EVIDENCE FOR PUBLIC HEALTHCARE SUSTAINABILITY.Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?Percentage incidence of gamma-aminobutyric acid neurons in the claustrum of the rabbit and comparison with the cortex and putamen.Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry.[Prevalence of certain osteoporosis-determining habits among post menopausal women in the Basque Country, Spain, in 2003].CAPACITY BUILDING IN AGENCIES FOR EFFICIENT AND EFFECTIVE HEALTH TECHNOLOGY ASSESSMENT.QUALITY ASSESSMENT OF ETHICS ANALYSES FOR HEALTH TECHNOLOGY ASSSESSMENT.Addressing issues in health technology assessment promotion: Motives, enablers, and barriers.STATUS OF DISINVESTMENT INITIATIVES IN LATIN AMERICA: RESULTS FROM A SYSTEMATIC LITERATURE REVIEW AND A QUESTIONNAIRE.Public health genomics in Spain: the status of a non-existing reality.Scanning the horizon of obsolete technologies: possible sources for their identification.The Learning-Adapting-Leveling model: from theory to hypothesis of steps for implementation of basic genome-based evidence in personalized medicineFactors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical testGABAergic neurons in the rabbit visual cortex: percentage, layer distribution and cortical projectionsTHE EVOLUTION OF EARLY AWARENESS AND ALERT METHODS AND SYSTEMS[Predictive value of ultra-sound densitometry as a method of selective screening for osteoporosis in primary care]Biomedical literature search protocols: consensus statement from the documentation units of the Spanish health technology assessment agencies[Evidence based comparative analysis for managing osteoporosis in a primary health care setting][Evidence-based disinvestment in Spain]Differences in the identification process for new and emerging health technologies: analysis of the EuroScan databaseENVIRONMENTAL IMPACT ASSESSMENT OF A HEALTH TECHNOLOGY: A SCOPING REVIEWDisinvestment Activities and Candidates in the Health Technology Assessment Community: An Online SurveyParticipation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 yearsScreening colonoscopy and risk of adverse events among individuals undergoing fecal immunochemical testing in a population-based program: A nested case-control studyAn evidence-based framework for identifying technologies of no or low-added value (NLVT)
P50
Q28087503-7E8BB740-6C86-4AAF-AE34-4140FE773012Q33599540-30C9BEE9-F7E4-4E73-B43C-212623A3262CQ33711055-CD558770-3E04-4E75-874A-6B3E2C05E604Q33730353-2FAF31A3-8A84-45A2-AFFA-B0AD520CF0F2Q34011689-84F71959-6099-43E4-8D23-ABDCC77935F6Q34501500-518AA2FE-CD39-4493-B3BB-2907ABC7BE70Q35144339-B8F2AACE-2130-4ACB-9546-15C4177CEA73Q36443118-72D88C07-41BF-42A4-91C4-46368BCC4370Q36841028-1D413CB1-9DA1-44B1-B087-55556172E31DQ37207395-527DB97E-DCD2-4468-AFA9-4ACEC4F30142Q37601340-8D09009D-8CAF-4B9C-88C1-D357FA4EB6B8Q37773696-02B1E963-055A-4820-A5CE-A85738593443Q38043664-B9A4CD77-A539-430E-A592-AB1B5460354AQ39391967-50D7D30D-444B-44A9-964A-4CAA548D2056Q41557427-EB665F40-7166-48FD-9BC3-D5FF27B2BD80Q42484988-05F67062-A05F-4F9C-BA3B-5B6553D688D8Q42625889-0203917D-A9A5-4D30-9ACF-4486756A83F5Q46695988-8B3E01E3-B006-46A0-9BAB-74FEC171CBE3Q47267534-3E8464DD-6073-4036-AE53-7B849B38869DQ47610929-3421E436-9AEF-4786-AD64-9D879849DD18Q48158009-1EF8B8D8-30B2-489F-9010-85C5EDC02DE3Q48583905-13ADBF19-C836-4C9B-A83B-0797DE1CEE4FQ53133752-878C4013-0EF5-407B-9824-47E101DEE4F5Q53190573-F29F832E-2AB9-4CAA-B900-5BE3BE4BC607Q57899357-32DBC995-D837-4740-A783-151309864071Q58221548-95AB85F0-DA25-4EE8-BA3D-22F169FC69CBQ59295205-6CAF2AAC-2DE6-464E-91D0-9495316CF49EQ63379342-81ECBA99-D8BB-4AEE-86E8-6C87E3C978D2Q80233207-A05D4ED7-9531-471A-9EF3-7B69329F19C0Q80545544-8D6CB57F-3510-4A90-990C-6EF8D604A249Q82835144-1A1FF9A4-C78A-4836-84FC-C7286FD852AFQ83020757-553AA5C4-A025-4FE1-8587-7BFDB57D046CQ84259286-573F24FC-4ACC-46F2-8F12-1B71BA2B6D75Q89086811-A044FEFF-6D25-4F6E-A86B-28EF710C71B3Q90046781-8F069BD5-77FC-48DA-912E-4452CA5EB3E1Q90448590-3CD95D84-E6D7-4BE6-9F46-5EA709F8B83AQ90791481-4F1AC932-2C4E-478D-A9F0-A7EA601EE0DAQ91926280-6CCF5603-64E2-4247-A55E-8DF18F7550F7
P50
description
researcher
@en
name
I Gutiérrez-Ibarluzea
@en
I Gutiérrez-Ibarluzea
@nl
type
label
I Gutiérrez-Ibarluzea
@en
I Gutiérrez-Ibarluzea
@nl
prefLabel
I Gutiérrez-Ibarluzea
@en
I Gutiérrez-Ibarluzea
@nl
P106
P31
P496
0000-0002-4080-7963